Treatments for NAFLD
Non-alcoholic fatty liver disease (NAFLD) is categorised into simple steatosis, termed nonalcoholic fatty liver (NAFL) and nonalcoholic steatohepatitis (NASH). Nonalcoholic steatohepatitis is characterized by steatosis, hepatocyte damage, inflammation and liver fibrosis, which through cirrhosis lead...
Saved in:
Main Author: | Katarzyna Juszczyńska (Author) |
---|---|
Format: | Book |
Published: |
Polish Pharmaceutical Society,
2021-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
NAFLD and Diabetes: Two Sides of the Same Coin? Rationale for Gene-Based Personalized NAFLD Treatment
by: Ming-Feng Xia, et al.
Published: (2019) -
Genetic Factors Associated with Response to Vitamin E Treatment in NAFLD
by: Mehtap Civelek, et al.
Published: (2022) -
Treatment of NAFLD: Diet, Physical Activity, and Potential Pharmacological Options
by: Justyna Śliz, et al.
Published: (2024) -
The NAFLD fibrosis score : a prognostic predictor for mortality and liver complications among NAFLD patients
by: Sombat Treeprasertsuk
Published: (2013) -
Genetic implications in patients with NAFLD
by: Jakub Misiak, et al.
Published: (2024)